Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Current Medicinal Chemistry
|
January 5, 2012
Synthesis and antinociceptive behaviors of new methyl and hydroxyl derivatives of phencyclidine
A Ahmadi, M Kermani, N Naderi, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|
December 11, 2012
Effect of phencyclidine derivatives on anxiety-like behavior using an elevated-plus maze test in mice
Ramin Hajikhani, Abbas Ahmadi, Nima Naderi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2022
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade
X M Shao, J Huang, N Niknafs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2018
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
T R Cottrell, E D Thompson, P M Forde, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Current Medicinal Chemistry
|
January 5, 2012
Synthesis and antinociceptive behaviors of new methyl and hydroxyl derivatives of phencyclidine
A Ahmadi, M Kermani, N Naderi, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|
December 11, 2012
Effect of phencyclidine derivatives on anxiety-like behavior using an elevated-plus maze test in mice
Ramin Hajikhani, Abbas Ahmadi, Nima Naderi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2022
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade
X M Shao, J Huang, N Niknafs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2018
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
T R Cottrell, E D Thompson, P M Forde, et al.
Page
of 1